Sommadossi Jean-Pierre
- SEC CIK
- 0001296995
No open-market purchases or sales filed in the past year.
Current role at each company
- AVIR Atea Pharmaceuticals, Inc.President, CEO, and Chairmanas of Feb 3, 2026
- ABGI ABG Acquisition Corp. IDirectoras of Mar 3, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sommadossi Jean-Pierre as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AVIR Atea Pharmaceuticals, Inc.
President, CEO, and Chairman3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2024 (view filing) | Sep 17-19 | 2 days | Sommadossi Jean-PierrePresident, CEO, and Chairman | SSale | −58.0K | $4.04 | −$234.2K | −1.0%5.87M after | 3 lots10b5-1 |
| Jun 7, 2024 (view filing) | Jun 5 | 2 days | Sommadossi Jean-PierrePresident, CEO, and Chairman | SSale | −1.01K | $4.00 | −$4.02K | 0.0%5.92M after | 10b5-1 |
| Feb 2, 2024 (view filing) | Feb 1 | 1 day | Sommadossi Jean-PierrePresident, CEO, and Chairman | SSale | −56.9K | $3.85 | −$219.1K | −32.8%116.6K after | 10b5-1 |